136 related articles for article (PubMed ID: 2789298)
21. PET using 11C-methionine in recognition of pseudoprogression in cerebral glioma after combined treatment.
Skvortsova TY; Brodskaya ZL; Gurchin AF
Zh Vopr Neirokhir Im N N Burdenko; 2014; 78(4):50-8. PubMed ID: 25406809
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma.
Nariai T; Tanaka Y; Wakimoto H; Aoyagi M; Tamaki M; Ishiwata K; Senda M; Ishii K; Hirakawa K; Ohno K
J Neurosurg; 2005 Sep; 103(3):498-507. PubMed ID: 16235683
[TBL] [Abstract][Full Text] [Related]
23. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
Okubo S; Zhen HN; Kawai N; Nishiyama Y; Haba R; Tamiya T
J Neurooncol; 2010 Sep; 99(2):217-25. PubMed ID: 20091333
[TBL] [Abstract][Full Text] [Related]
24. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
25. 11C-methionine PET for differential diagnosis of low-grade gliomas.
Herholz K; Hölzer T; Bauer B; Schröder R; Voges J; Ernestus RI; Mendoza G; Weber-Luxenburger G; Löttgen J; Thiel A; Wienhard K; Heiss WD
Neurology; 1998 May; 50(5):1316-22. PubMed ID: 9595980
[TBL] [Abstract][Full Text] [Related]
26. PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids.
Bergström M; Ericson K; Hagenfeldt L; Mosskin M; von Holst H; Norén G; Eriksson L; Ehrin E; Johnström P
J Comput Assist Tomogr; 1987; 11(2):208-13. PubMed ID: 3493274
[TBL] [Abstract][Full Text] [Related]
27. Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma.
Ullrich RT; Kracht L; Brunn A; Herholz K; Frommolt P; Miletic H; Deckert M; Heiss WD; Jacobs AH
J Nucl Med; 2009 Dec; 50(12):1962-8. PubMed ID: 19910435
[TBL] [Abstract][Full Text] [Related]
28. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine.
Langen KJ; Mühlensiepen H; Holschbach M; Hautzel H; Jansen P; Coenen HH
J Nucl Med; 2000 Jul; 41(7):1250-5. PubMed ID: 10914918
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining.
Sato N; Suzuki M; Kuwata N; Kuroda K; Wada T; Beppu T; Sera K; Sasaki T; Ogawa A
Neurosurg Rev; 1999 Dec; 22(4):210-4. PubMed ID: 10682929
[TBL] [Abstract][Full Text] [Related]
30. Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography.
Mineura K; Sasajima T; Kowada M; Uesaka Y; Shishido F
J Nucl Med; 1991 Apr; 32(4):726-8. PubMed ID: 2013813
[TBL] [Abstract][Full Text] [Related]
31. (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: A stereotactic image-histology comparison.
Okita Y; Kinoshita M; Goto T; Kagawa N; Kishima H; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
Neuroimage; 2010 Feb; 49(4):2977-82. PubMed ID: 19931401
[TBL] [Abstract][Full Text] [Related]
32. Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography.
Hatazawa J; Ishiwata K; Itoh M; Kameyama M; Kubota K; Ido T; Matsuzawa T; Yoshimoto T; Watanuki S; Seo S
J Nucl Med; 1989 Nov; 30(11):1809-13. PubMed ID: 2809745
[TBL] [Abstract][Full Text] [Related]
33. [MET-PET in low-grade glioma. Safe way to follow disease progression and treatment].
Smits A; Savitcheva I; Ribom D
Lakartidningen; 2007 Jan 31-Feb 6; 104(5):326-30. PubMed ID: 17328356
[No Abstract] [Full Text] [Related]
34. [11C]L-methionine uptake in gliomas.
Derlon JM; Bourdet C; Bustany P; Chatel M; Theron J; Darcel F; Syrota A
Neurosurgery; 1989 Nov; 25(5):720-8. PubMed ID: 2586726
[TBL] [Abstract][Full Text] [Related]
35. Non selective transport of [11C-methyl]-L-and D-methionine into a malignant glioma.
Schober O; Duden C; Meyer GJ; Müller JA; Hundeshagen H
Eur J Nucl Med; 1987; 13(2):103-5. PubMed ID: 3038558
[TBL] [Abstract][Full Text] [Related]
36. Early delineation of cerebral glioma using amino acid positron tracers.
Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Uemura K
Comput Med Imaging Graph; 1997; 21(1):63-6. PubMed ID: 9118072
[TBL] [Abstract][Full Text] [Related]
37. The accumulation of 11C-methionine in cerebral glioma patients studied with PET.
Kameyama M; Shirane R; Itoh J; Sato K; Katakura R; Yoshimoto T; Hatazawa J; Itoh M; Ido T
Acta Neurochir (Wien); 1990; 104(1-2):8-12. PubMed ID: 2386094
[TBL] [Abstract][Full Text] [Related]
38. [High uptake on 11C methionine PET scan in the pituitary gland of a patient with cerebral glioma after surgical abortion].
Hanakawa K; Ikeda H; Ishii K; Asamoto S; Iwata T; Matsumoto K
No To Shinkei; 1998 Jun; 50(6):573-7. PubMed ID: 9656254
[TBL] [Abstract][Full Text] [Related]
39. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
[TBL] [Abstract][Full Text] [Related]
40. Potential significance of (11)C-methionine PET as a marker for the radiosensitivity of low-grade gliomas.
Ribom D; Engler H; Blomquist E; Smits A
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):632-40. PubMed ID: 11976801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
